Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Myeloma, Newly Diagnosed”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01346787
What this trial is testing

Carfilzomib, Cyclophosphamide and Dexamethasone In Newly Diagnosed Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
European Myeloma Network B.V. 58
Testing effectiveness (Phase 2)Study completedNCT02937571
What this trial is testing

High Dose Carfilzomib for Newly Diagnosed Myeloma

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 29
Testing effectiveness (Phase 2)Looking for participantsNCT06974786
What this trial is testing

Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma

Who this might be right for
Multiple Myeloma, Newly DiagnosedMultiple Myeloma (MM)
SCRI Development Innovations, LLC 100
Early research (Phase 1)Ended earlyNCT01807286
What this trial is testing

Pomalidomide With Melphalan and Dexamethasone for Untreated Systemic AL Amyloidosis

Who this might be right for
Myeloma
M.D. Anderson Cancer Center 3
Testing effectiveness (Phase 2)UnknownNCT00526734
What this trial is testing

High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Newly Diagnosed Stage I, Stage II, or Stage III Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Erasme University Hospital 100
Testing effectiveness (Phase 2)Looking for participantsNCT06993675
What this trial is testing

Engaging T-cells to Eliminate MRD in Newly Diagnosed Myeloma Optimizing Response With Talquetmab and Teclistamab (ROTATE)

Who this might be right for
Multiple Myeloma
Noffar Bar 50
Testing effectiveness (Phase 2)Ended earlyNCT03218163
What this trial is testing

MEDI-551 as Maintenance Therapy After Allogeneic Stem Cell Transplant in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 1
Large-scale testing (Phase 3)Study completedNCT02406144
What this trial is testing

Trial Studying Maintenance Treatment With Lenalidomide and Dexamethasone Versus Lenalidomide, Dexamethasone and MLN9708 After Autologous Hematopoietic Stem Cell Transplantation in Patients With Newly-diagnosed Symptomatic Multiple Myeloma

Who this might be right for
Multiple Myeloma
PETHEMA Foundation 316
Testing effectiveness (Phase 2)Study completedNCT01279694
What this trial is testing

Trial of Carfilzomib Plus Melphalan and Prednisone in Elderly Untreated Patients With Multiple Myeloma (CARMYSAP)

Who this might be right for
Myeloma
Nantes University Hospital 72
Large-scale testing (Phase 3)Looking for participantsNCT05623020
What this trial is testing

Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant

Who this might be right for
Multiple Myeloma
Pfizer 1,060
Testing effectiveness (Phase 2)UnknownNCT05280275
What this trial is testing

Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Transplant Ineligible

Who this might be right for
Multiple MyelomaNeoplasmsNeoplasms, Plasma Cell+5 more
Hellenic Society of Hematology 36
Large-scale testing (Phase 3)Study completedNCT01335399
What this trial is testing

Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Newly Diagnosed, Previously Untreated Multiple Myeloma

Who this might be right for
Multiple Myeloma
Bristol-Myers Squibb 748
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06931704
What this trial is testing

Comparison of Elranatamab and Lenalidomide Versus Daratumumab and Lenalidomide as Post-transplant Maintenance Therapy in Patients With Newly Diagnosed Myeloma (ElMMA)

Who this might be right for
Multiple Myeloma
Nantes University Hospital 176
Testing effectiveness (Phase 2)Study completedNCT02874742
What this trial is testing

Study Comparing Daratumumab, Lenalidomide, Bortezomib, and Dexamethasone (D-RVd) Versus Lenalidomide, Bortezomib, and Dexamethasone (RVd) in Subjects With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 224
Large-scale testing (Phase 3)UnknownNCT00546988
What this trial is testing

Multi Centre Trial of DSMM for Newly Diagnosed Multiple Myeloma up to 60 Years

Who this might be right for
Multiple Myeloma
University of Wuerzburg 600
Testing effectiveness (Phase 2)Study completedNCT04151667
What this trial is testing

Daratumumab Based Response Adapted Therapy for Older Adults With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
H. Lee Moffitt Cancer Center and Research Institute 33
Large-scale testing (Phase 3)UnknownNCT06324266
What this trial is testing

Study on the Efficacy and Safety of Low-dose CTX as Maintenance Therapy for MM Unsuitable for Transplantation

Who this might be right for
Newly Diagnosed Multiple Myeloma
Jinling Hospital, China 80
Testing effectiveness (Phase 2)Looking for participantsNCT05145400
What this trial is testing

Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple MyelomaCancer
UNC Lineberger Comprehensive Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT00478218
What this trial is testing

Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Mayo Clinic 53
Large-scale testing (Phase 3)UnknownNCT04287660
What this trial is testing

Study of BiRd Regimen Combined With BCMA CAR T-cell Therapy in Newly Diagnosed Multiple Myeloma (MM) Patients

Who this might be right for
Multiple Myeloma
The First Affiliated Hospital of Soochow University 20
Next Page